Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:1340 (3 December), doi:10.1136/bmj.331.7528.1340-a
| The first 150 words of the full text of this article appear below. |
EDITORThe Association of British Clinical Diabetologists (ABCD) welcomes Kenny's editorial on the impact of the quality and outcomes framework on diabetes management and supports his plea for supporting and strengthening secondary (specialist) care diabetes services.1
The implementation of the updated contract for general medical services (GMS2) has resulted in a welcome increase in the monitoring of patients, especially those with type 2 diabetes, who have been comparatively neglected in the past. However, the need to improve glycaemic control to meet the target value of 7.5% for HbA1c has had some unforeseen consequences. In most specialist centres, referrals of patients treated with tablets for consideration of insulin treatment have increased, and many general practices do not feel confident with this. Simultaneously, it is not only extremely difficult for secondary care to attract additional resources, but there is actual "downsizing" of some specialist units by local primary care trusts, in
Richard Greenwood, chairman
richard.greenwood@nnuh.nhs.uk
Association of British Clinical Diabetologists, c/o Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UY
Ken Shaw, treasurer, Peter Winocour, secretary
Association of British Clinical Diabetologists, c/o Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UY